125 related articles for article (PubMed ID: 34894284)
1. Correction to: FDG-PET/CT in colorectal cancer: potential for vascular-metabolic imaging to provide markers of prognosis.
Chen SH; Miles K; Taylor SA; Ganeshan B; Rodriquez M; Fraioli F; Wan S; Afaq A; Shortman R; Walls D; Hoy L; Endozo R; Bhargava A; Hanson M; Huang J; Raouf S; Francis D; Siddiqi S; Arulampalam T; Sizer B; Machesney M; Reay-Jones N; Dindyal S; Ng T; Groves AM
Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):786-787. PubMed ID: 34894284
[No Abstract] [Full Text] [Related]
2. Prospective study on diagnostic and prognostic significance of postoperative FDG PET/CT in recurrent colorectal carcinoma patients: comparison with MRI and tumor markers.
Odalovic S; Stojiljkovic M; Sobic-Saranovic D; Pandurevic S; Brajkovic L; Milosevic I; Grozdic-Milojevic I; Artiko V
Neoplasma; 2017; 64(6):954-961. PubMed ID: 28895416
[TBL] [Abstract][Full Text] [Related]
3. Radiomic analysis for predicting prognosis of colorectal cancer from preoperative
Lv L; Xin B; Hao Y; Yang Z; Xu J; Wang L; Wang X; Song S; Guo X
J Transl Med; 2022 Feb; 20(1):66. PubMed ID: 35109864
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of Intratumor Metabolic Heterogeneity Parameters on
Liu X; Xiang K; Geng GY; Wang SC; Ni M; Zhang YF; Pan HF; Lv WF
Contrast Media Mol Imaging; 2022; 2022():2586245. PubMed ID: 35173559
[TBL] [Abstract][Full Text] [Related]
5. Value of CT, FDG PET-CT and serum tumor markers in staging recurrent colorectal cancer.
Caglar M; Yener C; Karabulut E
Int J Comput Assist Radiol Surg; 2015 Jul; 10(7):993-1002. PubMed ID: 25213271
[TBL] [Abstract][Full Text] [Related]
6. Impact of 18F-FDG PET/CT on therapeutic decisions in patients with colorectal cancer and liver metastases.
Georgakopoulos A; Pianou N; Kelekis N; Chatziioannou S
Clin Imaging; 2013; 37(3):536-41. PubMed ID: 23116727
[TBL] [Abstract][Full Text] [Related]
7. A pilot study for texture analysis of
Nakajo M; Kajiya Y; Tani A; Jinguji M; Nakajo M; Kitazono M; Yoshiura T
Eur J Nucl Med Mol Imaging; 2017 Dec; 44(13):2158-2168. PubMed ID: 28770274
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Total Lesion Glycolysis Measured by 18F-FDG-PET/CT in Patients with Colorectal Cancer.
Ogawa S; Itabashi M; Kondo C; Momose M; Sakai S; Kameoka S
Anticancer Res; 2015 Jun; 35(6):3495-500. PubMed ID: 26026116
[TBL] [Abstract][Full Text] [Related]
9. [Importance of FDG-PET/computed tomography in colorectal cancer].
Kleiner S; Weber W
Radiologe; 2019 Sep; 59(9):812-819. PubMed ID: 31428810
[TBL] [Abstract][Full Text] [Related]
10. Predictive Value of Metabolic Parameters Derived From
Liu H; Ye Z; Yang T; Xie H; Duan T; Li M; Wu M; Song B
Front Immunol; 2021; 12():724464. PubMed ID: 34512653
[TBL] [Abstract][Full Text] [Related]
11. Information feedback of
Mu Y; Gui J; Lang Z; Ren C; Yan L; Liu H; Liang J; Feng H
J Infect Public Health; 2020 Sep; 13(9):1336-1341. PubMed ID: 31289004
[TBL] [Abstract][Full Text] [Related]
12. PET and PET-CT for evaluation of colorectal carcinoma.
Delbeke D; Martin WH
Semin Nucl Med; 2004 Jul; 34(3):209-23. PubMed ID: 15202102
[TBL] [Abstract][Full Text] [Related]
13. Differences on metabolic behavior between intra and extrahepatic cholangiocarcinomas at
Sabaté-Llobera A; Gràcia-Sánchez L; Reynés-Llompart G; Ramos E; Lladó L; Robles J; Serrano T; Mestres-Martí J; Gámez-Cenzano C
Clin Transl Oncol; 2019 Mar; 21(3):324-333. PubMed ID: 30022384
[TBL] [Abstract][Full Text] [Related]
14. Clinical Value of (18)F-FDG- PET-CT in the Preoperative Staging of Peritoneal Carcinomatosis from Colorectal Origin.
De Vos N; Goethals I; Ceelen W
Acta Chir Belg; 2014; 114(6):370-5. PubMed ID: 26021680
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of FDG-PET/CT for lymph node metastasis of colorectal cancer.
Kwak JY; Kim JS; Kim HJ; Ha HK; Yu CS; Kim JC
World J Surg; 2012 Aug; 36(8):1898-905. PubMed ID: 22526032
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic value of
Zhang XC; Zhang JH; Wang RF; Fan Y; Fu ZL; Yan P; Zhao GY; Bai YX
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Dec; 51(6):1071-1077. PubMed ID: 31848507
[TBL] [Abstract][Full Text] [Related]
17. 18F-FDG PET/CT metabolic parameters and HER2 expression in colorectal cancer.
Yang Z; Liu S; Sun Y; Xu J; Jiang J; Ma X; Zhang Y; Song S
Neoplasma; 2021 Jul; 68(4):875-881. PubMed ID: 33998235
[TBL] [Abstract][Full Text] [Related]
18. Preoperative imaging for colorectal liver metastases: a nationwide population-based study.
Elfrink AKE; Pool M; van der Werf LR; Marra E; Burgmans MC; Meijerink MR; den Dulk M; van den Boezem PB; Te Riele WW; Patijn GA; Wouters MWJM; Leclercq WKG; Liem MSL; Gobardhan PD; Buis CI; Kuhlmann KFD; Verhoef C; Besselink MG; Grünhagen DJ; Klaase JM; Kok NFM;
BJS Open; 2020 Aug; 4(4):605-621. PubMed ID: 32374497
[TBL] [Abstract][Full Text] [Related]
19. Statistical Modeling of Relations Between PET/CT Parameters and CEA in Recurrent and Metastatic Colorectal Cancer.
Milardovic R; Dzananovic L; Beslija S; Beslic N; Puhalovic A; Cavaljuga S
Acta Inform Med; 2023 Jun; 31(2):115-120. PubMed ID: 37711491
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment.
Niekel MC; Bipat S; Stoker J
Radiology; 2010 Dec; 257(3):674-84. PubMed ID: 20829538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
